Université catholique de Louvain, Louvain Drug Research Institute, Clinical Pharmacy Research Group, Brussels, Belgium; Université catholique de Louvain, CHU UCL Namur, Department of Pharmacy, Yvoir, Belgium.
Université catholique de Louvain, CHU UCL Namur, Department of Nuclear Medicine, Yvoir, Belgium; Université catholique de Louvain, Institute of Health and Society, Brussels, Belgium.
Thromb Res. 2020 Mar;187:79-87. doi: 10.1016/j.thromres.2019.12.023. Epub 2020 Jan 7.
Serious adverse drug reactions have been associated with the underuse or the misuse of oral anticoagulant therapy. We systematically reviewed the impact of computerized clinical decision support systems (CDSS) on the prescribing of oral anticoagulants and we described CDSS features associated with success or failure.
We searched Medline, Embase, CENTRAL, CINHAL, and PsycINFO for studies that compared CDSS for the initiation or monitoring of oral anticoagulants with routine care. Two reviewers performed study selection, data collection, and risk-of-bias assessment. Disagreements were resolved with a third reviewer. Potentially important CDSS features, identified from previous literature, were evaluated.
Sixteen studies were included in our qualitative synthesis. Most trials were performed in primary care (n = 7) or hospitals (n = 6) and included atrial fibrillation (AF) patients (n = 9). Recommendations mainly focused on anticoagulation underuse (n = 11) and warfarin-drug interactions (n = 5). Most CDSS were integrated in electronic records or prescribing and provided support automatically at the time and location of decision-making. Significant improvements in practitioner performance were found in 9 out of 16 studies, while clinical outcomes were poorly reported. CDSS features seemed slightly more common in studies that demonstrated improvement.
CDSS might positively impact the use of oral anticoagulants in AF patients at high risk of stroke. The scope of CDSS should now evolve to assist prescribers in selecting the most appropriate and tailored medication. Efforts should nevertheless be made to improve the relevance of notifications and to address implementation outcomes.
严重药物不良反应与口服抗凝剂治疗的使用不足或使用不当有关。我们系统地回顾了计算机临床决策支持系统(CDSS)对口服抗凝剂处方的影响,并描述了与成功或失败相关的 CDSS 特征。
我们在 Medline、Embase、CENTRAL、CINHAL 和 PsycINFO 中搜索了比较启动或监测口服抗凝剂时使用 CDSS 与常规护理的研究。两名评审员进行了研究选择、数据收集和偏倚风险评估。如有分歧,则由第三名评审员解决。从之前的文献中确定了可能重要的 CDSS 特征,并进行了评估。
我们的定性综合分析纳入了 16 项研究。大多数试验是在初级保健机构(n=7)或医院(n=6)进行的,纳入了房颤(AF)患者(n=9)。建议主要集中在抗凝剂使用不足(n=11)和华法林药物相互作用(n=5)上。大多数 CDSS 都集成在电子病历或处方中,并在决策时和地点自动提供支持。在 16 项研究中有 9 项发现医生的表现显著改善,而临床结果的报告较差。在显示出改善的研究中,CDSS 特征似乎更为常见。
CDSS 可能会积极影响 AF 患者中风高危人群中口服抗凝剂的使用。CDSS 的范围现在应该发展到帮助医生选择最合适和最适合的药物。然而,应努力提高通知的相关性,并解决实施结果。